• Market Shortage Response from Akorn... Read More
  • Now Available - Sodium Diuril, Cogentin, and Nembutal Injection... Read More
  • AK-FluorŽ 10% and ParemydŽ Available Now!... Read More

Investor News


webcast     Akorn, Inc. First Quarter 2012 Conference Call
Date/Time: Tuesday, May 8, 2012, at 10:00 a.m. Eastern Time
Domestic Callers: (877) 723-9517
International Callers: (719) 325-4747
Confirmation Code: 3062574
URL For Webcast: http://www.videonewswire.com/event.asp?id=86591
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
NOTICE OF RIGHT TO CONVERT
Read More
Akorn Acquires Three Hospital-Based Branded Injectables from Lundbeck
Read More
Akorn Reports Record Third Quarter 2011 Financial Results
Read More
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Press Releases


04.17.2012   Akorn, Inc. Announces First Quarter 2012 Earenings Release AND Conference Call Information  
  Read More
04.10.2012   Akorn Announces the Approval and Launch of Generic VancocinŽ  
  Read More
03.06.2012   Akorn Reports 2011 Fourth Quarter and Year-End Financial Results  
  Read More
03.05.2012   Akorn Announces the Appointment of Dr. Adrienne Graves, Ph.D. to its Board of Directors  
  Read More
02.28.2012   Akorn Completes the Acquisition of Certain Assets of Kilitch Drugs in India  
  Read More
02.07.2012   Fourth Quarter 2011 Earnings Release and Conference Call Information  
  Read More
01.17.2012   Akorn Provides Financial Guidance for 2012  
  Read More
12.22.2011   Akorn Acquires Three Hospital-Based Branded Injectables from Lundbeck  
  Read More
11.01.2011   Akorn Reports Record Third Quarter 2011 Financial Results  
  Read More
10.07.2011   Akorn, Inc. Announces Third Quarter 2011 Earnings Release and Conference Call Information  
  Read More
10.06.2011   Akorn Enters Into an Agreement to Acquire Certain Assets of Kilitch Drugs in India  
  Read More
08.02.2011   Akorn Reports Second Quarter 2011 Financial Results  
  Read More
08.02.2011   Akorn to Acquire a Minority Stake in Aciex Therapeutics  
  Read More
06.23.2011   Akorn, Inc. Announces Second Quarter 2011 Earnings Release and Conference Call Information  
  Read More
06.02.2011   Akorn Announces Closing of $120 Million of Convertible Senior Notes Due 2016  
  Read More
05.26.2011   Akorn Announces Pricing of $100 Million of Convertible Senior Notes Due 2016  
  Read More
05.25.2011   Akorn Announces Proposed Offering of $100 Million of Convertible Senior Notes Due 2016  
  Read More
05.03.2011   Akorn Reports First Quarter 2011 Financial Results  
  Read More
05.03.2011   Akorn Enters Into an Agreement to Acquire Advanced Vision Research  
  Read More
04.07.2011   Akorn, Inc. Announces First Quarter 2011 Earnings Release and Conference Call Information  
  Read More
02.28.2011   Akorn Reports 2010 Fourth Quarter and Year-End Financial Results - Achieves Annual Core Revenue Growth of 81% -  
  Read More
01.30.2011   Akorn, Inc. Announces Fourth Quarter 2010 Earnings Release and Conference Call Information  
  Read More
12.28.2010   Akorn Announces the Sale of the Akorn-Strides Joint Venture Product Portfolio to Pfizer, Inc.  
  Read More
10.31.2010   Akorn Reports Third Quarter 2010 Results; Core Revenues Increase by 118%; Adjusted EBITDA of $6.3 million; Raises Outlook for 2010  
  Read More
10.06.2010   Akorn, Inc. Announces Third Quarter 2010 Earnings Release and Conference Call Information  
  Read More
09.15.2010   Akorn Announces Launch of Erythromycin Ophthalmic Ointment USP 1 g  
  Read More
08.02.2010   Akorn Reports Second Quarter 2010 Financial Results -Core Revenues Increase by 138%- -Adjusted EBITDA of $4.2 million; Raises Earnings Outlook for 2010-  
  Read More
08.01.2010   Akorn, Inc. Announces Second Quarter 2010 Earnings Release and Conference Call Information  
  Read More
05.02.2010   Akorn Reports First Quarter 2010 Financial Results -Achieves Positive Operating Income from Strong Demand in Core Business- -Raises Outlook for 2010-  
  Read More
04.20.2010   Akorn Announces FDA Approval to Re-Launch Erythromycin Ophthalmic Ointment USP 3.5 g  
  Read More
04.18.2010   Akorn, Inc. Announces First Quarter 2010 Earnings Release and Conference Call Information  
  Read More
04.14.2010   Akorn, Inc. Announces FDA Approval for Hydromorphone Hydrochloride Injection 10mg/mL in 1mL, 5mL and 50mL Doses  
  Read More
03.14.2010   Akorn Reports 2009 Fourth Quarter and Year-End Financial Results -Achieves Positive Fourth Quarter Cash Flow and Adjusted EBITDA- -Refocuses R&D efforts to Strengthen New Product Pipeline-  
  Read More
03.10.2010   Akorn, Inc. Enters into an Agreement to Sell Common Stock and Warrants  
  Read More
02.08.2010   Akorn, Inc. Announces Fourth Quarter 2009 Earnings Release and Conference Call Information  
  Read More